hengrui glp 1 BMS signs $15.2bn R&D alliance with China's BioCentury - Hengrui and Kailera's
Description
Survey shows links to lower substance use and better impulse control.
Online telehealth for GLP-1 weight loss, TRT, HRT and IV therapy
For example, semaglutide and empagliflozin showed no significant difference in 3-point MACE (HR 1.05
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
